<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04245345</url>
  </required_header>
  <id_info>
    <org_study_id>AccelAV</org_study_id>
    <nct_id>NCT04245345</nct_id>
  </id_info>
  <brief_title>Accelerometer Sensing for Micra AV Study</brief_title>
  <acronym>AccelAV</acronym>
  <official_title>Accelerometer Sensing for Micra AV Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Cardiac Rhythm and Heart Failure</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic Cardiac Rhythm and Heart Failure</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the AccelAV Study is to characterize chronic AV synchrony in subjects
      implanted with MicraTM AV device. This study will be conducted upon market approval of the
      MicraTM AV Transcatheter Pacing System.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Accel AV study is a prospective, single-arm, global, multi-center clinical study to
      characterize the chronic AV synchrony in subjects implanted with the market released Micra AV
      system. The study is planned to be conducted in the US and Hong Kong. Overall, the study is
      expected to be conducted at approximately 20 centers.The expected total study duration is
      approximately 12-15 months, representing the time necessary to enroll the target sample size
      and to complete the 3-month follow-up visit.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">July 2020</start_date>
  <completion_date type="Anticipated">August 2021</completion_date>
  <primary_completion_date type="Anticipated">June 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>AV synchrony percentage during rest</measure>
    <time_frame>1-month post-implant</time_frame>
    <description>Characterize percentage of cardiac cycles during the 20-minute resting period at the 1-month follow-up visit, where a paced or sensed ventricular beat is within 300 ms following an ECG confirmed P-wave.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">175</enrollment>
  <condition>AV Block</condition>
  <condition>AV Block Complete</condition>
  <condition>3rd Degree Heart Block</condition>
  <condition>Complete Heart Block</condition>
  <arm_group>
    <arm_group_label>Single-arm</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Accelerometer Sensing for Micra AV Study</intervention_name>
    <description>Characterize AV synchrony in subjects implanted with Micra AV device. The study will be conducted upon market approval of the Micra AV Transcatheter Pacing System.</description>
    <arm_group_label>Single-arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Subject will be implanted with a MicraTM (Model MC1AVR1) for an approved indication.

          -  Subject has history of AV block.

          -  Subject is â‰¥ 18 years old and as per required local law.

          -  Subject (and/or witness as applicable per local regulations) provides signed and dated
             authorization and/or consent per institution and local requirements.

          -  Subject is willing and able to comply with the protocol.

        Exclusion Criteria:

          -  Subject currently enrolled or planning to participate in a potentially confounding
             drug or device trial during the study. Co-enrollment in concurrent trials is only
             allowed when documented pre-approval is obtained from the Medtronic Clinical Research
             Specialist.

          -  Subject implanted with a MicraTM (Model MC1AVR1) on a non-permanent basis (e.g. CIED
             infection).

          -  Subject is pregnant (if required by local law, women of child-bearing potential must
             undergo a pregnancy test within seven days prior to MicraTM Model MC1AVR1 implant
             procedures).

          -  Subject meets any exclusion criteria required by local law (age or other).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Larry Chinitz, MD</last_name>
    <role>Study Chair</role>
    <affiliation>NYU Langone</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nicole Wood</last_name>
    <phone>763-526-1525</phone>
    <email>Nicole.wood@medtronic.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Andrea Schminke</last_name>
    <phone>763-526-2623</phone>
    <email>Andrea.n.schminke@medtronic.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Baptist Heart Specialists</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32207</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeanine Richmond</last_name>
      <phone>904-202-3885</phone>
      <email>jeanine.richmond@bmcjax.com</email>
    </contact>
    <investigator>
      <last_name>Venkata Sagi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joel Eggebeen</last_name>
      <phone>404-712-0137</phone>
      <email>joel.eggebeen@emory.edu</email>
    </contact>
    <investigator>
      <last_name>Stacy Westerman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NYU Langone Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>April Jacob</last_name>
      <phone>212-263-7704</phone>
      <email>april.jacob@nyulangone.org</email>
    </contact>
    <investigator>
      <last_name>Larry Chinitz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mount Carmel Health System</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sheila Brooks</last_name>
      <phone>614-234-5814</phone>
      <email>sbrooks2@mchs.com</email>
    </contact>
    <investigator>
      <last_name>Kevin Hackett, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Thomas Jefferson University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Devon Magee</last_name>
      <phone>215-955-5050</phone>
      <email>devon.magee@jefferson.edu</email>
    </contact>
    <investigator>
      <last_name>Arnold Greenspon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baylor Research Institute</name>
      <address>
        <city>Plano</city>
        <state>Texas</state>
        <zip>75093</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gina Ortiz</last_name>
      <phone>469-814-4185</phone>
      <email>gina.ortiz@bswhealth.org</email>
    </contact>
    <investigator>
      <last_name>Brian DeVille</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>January 21, 2020</study_first_submitted>
  <study_first_submitted_qc>January 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 28, 2020</study_first_posted>
  <last_update_submitted>June 1, 2020</last_update_submitted>
  <last_update_submitted_qc>June 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>AV Synchrony</keyword>
  <keyword>Micra AV</keyword>
  <keyword>Micra</keyword>
  <keyword>Transcatheter Pacing</keyword>
  <keyword>Normal Sinus Node Function</keyword>
  <keyword>Leadless Pacemaker</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Block</mesh_term>
    <mesh_term>Atrioventricular Block</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

